ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Societe Generale Effekten

Societe Generale Effekten (S29581)

0.00
0.00
(0.00%)
Cerrado 26 Diciembre 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

S29581 Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AIREreAlpha Tech Corporation
US$ 3.5701
(160.59%)
130.88M
SPRCSciSparc Ltd
US$ 0.50
(126.04%)
239.51M
ZCARZoomcar Holdings Inc
US$ 2.80
(95.80%)
60.3M
MGIHMillennium Group International Holdings Ltd
US$ 2.9698
(94.10%)
75.35M
SKKSKK Holdings Limited
US$ 1.35
(80.48%)
52.11M
LNKSLinkers Industries Ltd
US$ 3.295
(-65.64%)
3.65M
GTIGraphjet Technology
US$ 0.3354
(-45.02%)
22.44M
BAOSBaosheng Media Group Holdings Ltd
US$ 4.3979
(-38.06%)
1.97M
NEUPNeuphoria Therapeutics Inc
US$ 4.34
(-34.54%)
599.97k
SVRESaverOne 2014 Ltd
US$ 1.0501
(-30.46%)
1.36M
XTIAXTI Aerospace Inc
US$ 0.0398
(1.53%)
270.76M
SPRCSciSparc Ltd
US$ 0.50
(126.04%)
239.51M
COEPCoeptis Therapeutics Holdings Inc
US$ 0.213249
(50.18%)
205.2M
RGTIRigetti Computing Inc
US$ 15.445
(36.08%)
204.3M
SMXSMX Security Matters Public Company
US$ 0.3303
(51.51%)
172.17M
rakp rakp 1 minuto hace
Charles Schwab won't allow trading anymore in this company.

Thanks to Chris and company for all the wonderful stories in the past......
TAGP
NickyCapone NickyCapone 3 minutos hace
This was just a brisk walk to .83 today‼️

$Tay tune for the Moon run once volume is here‼️
TAY
rickstereo3333 rickstereo3333 4 minutos hace
Apparently the Muppet doesn't understand what Vivos meant when they clearly stated,..."This milestone trial, which has commenced with the successful treatment of five patients with cancerous lymph nodes, represents a transformative step in advancing innovative cancer therapies.".

Hi
RDGL
JJ8 JJ8 5 minutos hace
Interesting check in chart that makes me laugh.

One could choose either interpretation:

1. Long Tail Up since 23-Dec-2024. This is negative and suggest price is likely to correct.

2.. Histogram bars pointing to likely recovery in share price.
DEFTF
BDEZ BDEZ 6 minutos hace
Hobbs & Fontes rigged 2 consecutive elections against Kari Lake

https://x.com/Real_RobN/status/1871965421470912693
6of1 6of1 6 minutos hace
you think AI is hot have a look at quantum
BBAI
norisknorewards norisknorewards 7 minutos hace
or they get (impo) approval the price explodes and shorts are destroyed.

End of the day...You, nor I, know what is coming. I am far more calm than you are.


That's what I am confident of
NWBO
BDEZ BDEZ 7 minutos hace
58% of Americans aged 65 and older have only $100,000 or less in their 401(k)s, per GoBankingRates.
BDEZ BDEZ 7 minutos hace
58% of Americans aged 65 and older have only $100,000 or less in their 401(k)s, per GoBankingRates.
willyw willyw 10 minutos hace
Yes, I'm enjoying the discussions. Yes, EDP 235 may never get a phase 3 trial- OTOH, if covid vaccinations continue to decline and IF another Delta like covid variant were to become prevalent we might wish we had a better drug than Paxlovid. And in spite of Paxlovid's possible inferiority to other c
ENTA
Genz2 Genz2 12 minutos hace
https://www.prnewswire.com/news-releases/nagravision-and-airties-partner-to-enhance-consumer-cybersecurity-for-homes-and-small-businesses-302265593.html

Excerpt:

NAGRAVISION solutions are designed to empower consumers and businesses to thrive in a connected world withou
Stockman1010101 Stockman1010101 13 minutos hace
he is no genius but a scam artists. He makes over $25 million per year salary when he causes the AMC stock to tank. He has not bought 1 AMC shares since he took over the CEO position in 2016. The man is WORST CEO OF ANY STRUGGLING CO IN WALLSTREET
 HE LIED AND DISTORTED THE TRUTH TO THE SHARE
AMC
SkyLimit2022 SkyLimit2022 15 minutos hace
Gro,

Are you sure that your statement reflects reality? I think you’re just posting random nonsense as usual. 😶

“Big Pharma companies focus on compelling science, intellectual property, and promising clinical trial data, not necessarily the company’s market l
BCRX
lakers17 lakers17 16 minutos hace
For sure. Those new OTC filing rules in 2021 killed the OTC overall and the created expert market was a death sentence for many OTCs. The one guy screaming that 2021 is back over and over is absurd as are his charts in OTCs, especially trip plays. They don't work in the OTC and no way a chart pre
PHIL
RealDutch RealDutch 18 minutos hace
We could easily lose the partners in Nigeria if Laxmi keeps sending these crappy emails. They are also on his email list. They will not understand WHAT THE HELL IS GOING ON HERE.

We have to end this HERE, and NOW. How can anyone disagree with this?
ITUP
123tom 123tom 21 minutos hace
👍️ look for patterns.
Measurement patterns.Fib retrace targets. Shoulder support levels. 1 dollar 2 dollar moves. Now 3 dollar. Need more time to see some patterns. I might defer to any insights from Citrati and his charts.
Steve/ sab... 🫡 your forecast was proved rig
AVXL
glens0 glens0 21 minutos hace
Read this post, "ASST 8-k just out. Got extension til June 16,2025 to regain compliance. Be interesting to see if they release news.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1920406/000121390024112672/ea0226060-8k_asset.htm
https://investorshub.advfn.com/boards/read_msg.aspx?mes
ASST
Not likely Not likely 21 minutos hace
Oh ffs...

What's with you meatheads???

This site is littered with you like.

Grade schoolers comprehend more then you lot.

The ignorance is astounding.


Smfh.
EEGI
JJ8 JJ8 24 minutos hace
Good to know that you are in charge. Thanks for the great response.

Let's do it right with with what looks like a great opportunity with SoundHound stock to make some mula.

Thanks for your wishes and in turn I wish you and other investors in SOUN the same.
SOUN
Hardazoak Hardazoak 24 minutos hace
100%
AABB
dstock07734 dstock07734 25 minutos hace
Repeat after me: One of the most amazing part about DCVax-L is that success in animal models translates to humans. We are talking about the translation of success not about good or bad animal models.

I really don't think you read hundreds of papers. Each of following trial had preclin
NWBO
Hardazoak Hardazoak 25 minutos hace
All you bashers need to go slow on that fetanyl/meth mix. Making you talk nonsense all day long, going in circles about yellow corn tortilla taco factory, Benny- russian mafia conspiracy.
AABB

Su Consulta Reciente

Delayed Upgrade Clock